Breast Cancer

Breast Cancer
2022-07-17T00:00:00.000+10:00
Ongoing

ASCENT 04

ASCENT 04
Breast cancer

A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients with Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer, Whose Tumours Express PD-L1

A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients with Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer, Whose Tumours Express PD-L1

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Breast

Study Phase

III

Trial Identifiers

Registration number: NCT05382286

https://clinicaltrials.gov/study/NCT05382286

 

 

GenesisCare Location(s)
North Shore
location pin icon

North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia

phone icon (02) 8037 4100 email icon admin.northshore@genesiscare.com
NSW
North Shore
Principal Investigator(s)
Medical Oncologist

Dr Sally Baron-Hay

FRACP MBBS

Dr Sally Baron-Hay
location pin icon

North Shore

View Profile
Profile Image - Dr Sally Baron-Hay

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.